Steven Kelly

Entity
Individual
Business address
C/O Innovive Pharmaceuticals, Inc., 555 Madison Avenue, 25 Th Floor, 10022 New York, NY
Insider ownership signature
/s/ Steven Kelly
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Steven Kelly has filed 19 SEC EDGAR filings since 5/5/2006

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing OWNERSHIP DOCUMENT Jan 30, 2025 Jan 28, 2025 001-36296
4 Open Document Open Filing FORM 4 Dec 23, 2024 Dec 20, 2024 001-38951
4 Open Document Open Filing OWNERSHIP DOCUMENT Jun 18, 2024 Jun 17, 2024 001-36296
4 Open Document Open Filing PRIMARY DOCUMENT Mar 1, 2024 Feb 28, 2024 001-38951
4 Open Document Open Filing OWNERSHIP DOCUMENT Feb 2, 2024 Jan 31, 2024 001-36296
4 Open Document Open Filing FORM 4 Aug 8, 2023 Aug 4, 2023 001-38951
4 Open Document Open Filing FORM 4 Jul 3, 2023 Jun 30, 2023 001-38951
4 Open Document Open Filing OWNERSHIP DOCUMENT Jun 8, 2023 Jun 6, 2023 001-36296
4 Open Document Open Filing OWNERSHIP DOCUMENT Mar 9, 2023 Mar 7, 2023 001-36296
3 Open Document Open Filing OWNERSHIP DOCUMENT Mar 9, 2023 Mar 7, 2023 001-36296
4 Open Document Open Filing FORM 4 Jun 27, 2022 Jun 24, 2022 001-38951
4 Open Document Open Filing FORM 4 Jul 26, 2021 Jul 16, 2021 001-38951
4 Open Document Open Filing FORM 4 Feb 17, 2021 Feb 12, 2021 001-38951
4 Open Document Open Filing FORM 4 Aug 30, 2019 Aug 29, 2019 001-38951
3 Open Document Open Filing FORM 3 Jun 21, 2019 Jun 21, 2019 001-38951